Sucker at al. described clinical cases of melanoma patients treated and not treated with immunotherapy, whose progressed lesions evolved into complete loss of the B2M gene, which was accompanied by decreased infiltration of T cells due to the loss of HLA class I and II proteins [36]. Here, B2M is linked to melanoma.